○yoshihiko noguchi^1,2, Shogo Sekikawa¹, Yutaka Nogaki¹, Yudai Satake¹, Norifumi Murashima¹, Takashi Kirisawa¹, Guido Schiffer³, Johannes Köebberling⁴, Tomoyasu Hirose^1,2, Toshiaki Sunazuka^1,2 (1. Graduate School of Infection Control Science, Kitasato University, 2. Ōmura Satoshi Memorial Institute, Kitasato University, 3. Bayer Animal Health GmbH, An Elanco Animal Health Company, 4. Bayer AG)

○Yukihiro Furuuchi¹, Yuki Hitomi¹, Tomomi Sasaki¹, Takehiro Okamoto¹, Genichiro Tsuji², Takashi Kurohara², Yosuke Demizu², Osamu Ohno¹, Kenji Matsuno³ (1. Grad. Sch. Adv. Eng., Kogakuin Univ., 2. NIHS, 3. Fac. Pharm., Yasuda Women’s Univ.)

○Masaya Kumashiro¹, Kosuke Ohsawa¹, Kazuo Shin-ya², Takayuki Doi¹ (1. Grad. Sch. Pharm. Sci., Tohoku Univ., 2. AIST)

Kosuke Ohsawa¹, ○Kazuki Yonemitsu¹, Takayuki Doi¹ (1. Grad. Sch. Pharm. Sci., Tohoku Univ.)

○Miho Yamaguchi¹, Saki Funabiki¹, Chie Ogasa², Ryota Sato², Yoshiko Murata³, Motofumi Suzuki⁴, Kosuke Namba² (1. Pharm. Sci., Tokushima Uni, 2. Tokushima Uni., Grad. Sch.. Biomed Sci., 3. SUNTORY Found. Life Sci., 4. Aichi Steel Corp.)